Target intelligence / Profile preview

Multiple immune and stromal cell populations

Molecular classification
Other
01

Overview

The term Multiple immune and stromal cell populations refers to the complex and heterogeneous assembly of various cell types within a tissue, most commonly discussed in the context of the tumor microenvironment (TME). Immune populations include T cells, B cells, natural killer cells, and myeloid-derived cells, while stromal populations consist of fibroblasts, endothelial cells, and pericytes (Binnewies et al., 2018, Nature Medicine). These cells interact through a dense network of cytokines, chemokines, and direct cell-cell contacts to regulate processes such as inflammation, angiogenesis, and immune evasion (NCI Dictionary of Cancer Terms, 2024). In many diseases, particularly cancer, the balance between these populations determines the rate of progression and the patient's response to therapy. However, because this term describes a broad biological system rather than a specific protein, enzyme, or receptor, it is not considered a discrete therapeutic target in the traditional pharmacological sense. Instead, it represents the multicellular environment where specific molecular targets, such as PD-1 or VEGF, are expressed and modulated.

Other names
Tumor microenvironmentTMEStromal-immune nicheMulticellular ecosystemTumor immune microenvironmentTIME
02

Mechanism of action

Not applicable as this refers to a heterogeneous collection of cell types rather than a single molecular entity.

03

Biological functions

Immune responseCell-cell communicationTissue homeostasisAngiogenesisExtracellular matrix remodeling
04

Disease associations

CancerInflammationFibrosisAutoimmune disease
05

Safety considerations

Systemic toxicityOff-target effects due to cellular heterogeneityCytokine release syndromeAutoimmunityImpaired wound healing
06

Biomarkers

Tumor-infiltrating lymphocytes (TILs)Cancer-associated fibroblasts (CAFs)Immune scorePD-L1 expressionCD8+ T cell density

Beyond the preview

Go deeper on Multiple immune and stromal cell populations.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple immune and stromal cell populations.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call